A carregar...
Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan
Elevated blood pressure (BP) is a major determinant of morbidity and mortality burden related to cardio‐metabolic risk. Current guidelines indicate that controlling and lowering BP promotes cardiovascular (CV) risk reduction. Among antihypertensive agents, angiotensin receptor blockers (ARBs) are ch...
Na minha lista:
| Publicado no: | Cardiovasc Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587798/ https://ncbi.nlm.nih.gov/pubmed/30358114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1755-5922.12471 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|